Australian ambassador visits CSL Behring
CSL Behring management welcomes Australian Ambassador to Germany Philip Green.
New R&D Campus in Marburg
Video: “Topping-out” milestone celebrated in Marburg for facility scheduled to open in 2022.
From immune system problems to bleeding disorders and more – plasma-based therapies treat many health conditions.
Hemophilia B gene therapy
CSL closes commercialization and license agreement for Hemophilia B gene therapy.
A Network for the Orphans of Medicine
The future of rare disease diagnostics in the focus of science and industry
Donation for “Menschenskinder Marburg e.V.”
Last year’s “Cents for a good cause” will benefit children and young people with mental illnesses.